Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-17

Clinical Trial Update: An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) [Phase 2]

View source ↗

Summary

A Phase 2 trial (ACROBAT Edge) evaluating paltusotine for acromegaly has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paltusotine (paltusotine)

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Acromegaly | Phase 2 | Status: COMPLETED | Results posted: 2025-02-17